Downregulation of Krüppel-like factor 14 accelerated cellular senescence and aging
Yuli Hou1, Qiao Song1, Yaqi Wang1
1Department of Clinical Laboratory, Xuanwu Hospital, National Clinical Research Center for Geriatric Diseases, Capital Medical University, Beijing, China.
Abstract:
Aging has been considered as a risk factor in many diseases, thus, comprehensively understanding the cellular and molecular mechanisms of delayed aging is important. Here we investigated whether Krüppel-like factor 14 (KLF14) is a suppressor of cellular senescence and aging. In our research, KLF14 levels significantly decreased not only in the lymphocytes of healthy people but also in the cells and tissues of mice with aging. We performed in vitro and in vivo experiments on cells and mice to reveal the function of KLF14 in aging. KLF14 deficiency facilitates cellular senescence and aging-related pathologies in C57BL/6J mice, whereas KLF14 overexpression attenuates cellular senescence. Mechanistically, KLF14 delays aging by binding to the POLD1 promoter to positively regulate POLD1 expression. Remarkably, cellular senescence mediated by KLF14 downregulation could be alleviated by POLD1 expression. In addition, perhexiline, an agonist of KLF14, could delay cellular senescence and aging-related pathologies in senescence-accelerated P8 mice by inducing POLD1 expression, as perhexiline could enhance the effect of KLF14's transcription activation to POLD1 by elevating the binding level of KLF14 to the POLD1 promoter. Our data indicate that KLF14 might be a critical element in aging by upregulating POLD1 expression, indicating that the activation of KLF14 may delay aging and aging-associated diseases.
Insights
Krüppel-like factor 14 (KLF14) suppresses cellular senescence and aging. Lower KLF14 levels accelerate aging, while KLF14 activation, potentially via perhexiline, delays aging and related diseases by boosting POLD1 expression.
Area of Science:
- Gerontology
- Molecular Biology
- Cellular Biology
Background:
- Aging is a significant risk factor for numerous diseases.
- Understanding the molecular mechanisms of aging is crucial for developing interventions.
- Krüppel-like factor 14 (KLF14) has been investigated for its role in aging processes.
Purpose of the Study:
- To investigate the role of Krüppel-like factor 14 (KLF14) as a suppressor of cellular senescence and aging.
- To elucidate the molecular mechanisms by which KLF14 influences aging.
- To explore therapeutic potential of KLF14 modulation in aging.
Main Methods:
- Measured KLF14 levels in human lymphocytes and aging mouse tissues.
- Conducted in vitro and in vivo experiments using KLF14-deficient and overexpressing cells and mice.
- Utilized molecular techniques to assess KLF14's effect on POLD1 promoter activity and expression.
- Administered perhexiline, a KLF14 agonist, to senescence-accelerated mice.
Main Results:
- KLF14 levels decreased with aging in humans and mice.
- KLF14 deficiency accelerated cellular senescence and aging pathologies in mice.
- KLF14 overexpression attenuated cellular senescence.
- KLF14 positively regulated POLD1 expression by binding to its promoter.
- POLD1 expression alleviated KLF14 downregulation-mediated senescence.
- Perhexiline delayed senescence and aging pathologies by enhancing KLF14's transcriptional activation of POLD1.
Conclusions:
- KLF14 acts as a critical suppressor of cellular senescence and aging.
- KLF14 delays aging by upregulating POLD1 expression.
- Activation of KLF14, potentially through compounds like perhexiline, may offer a therapeutic strategy to delay aging and associated diseases.
Related Concept Videos
Negative Regulator Molecules
Molecular Factors Affecting Cell Division
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...
Abnormal Proliferation
Regulation of the Unfolded Protein Response
DNA Damage can Stall the Cell Cycle
Somatic to iPS Cell Reprogramming


